Medico Remedies share news, announcements and annual reports
NSE: MEDICOBSE: 540937Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹19.22.
29 Oct: open ₹19.59, high ₹19.59, low ₹18.80
- Under NSE's long-term additional surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹158 Cr2,034th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.40
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,56,00480.6% delivered
Medico Remedies has 140 announcements on record, routine notices left out; none in the 30 days to 30 Oct 2026, the latest on 29 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Medico Remedies quarterly results
The board met on 13 Aug 2026 to consider financial results
Notice filed 10 Aug 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Medico Remedies annual reports, presentations and earnings calls
The company's own documents, latest first.Medico Remedies financials, year by year
Annual reports5
- Annual report, year to Mar 202629 Aug 2026
- Annual report, year to Mar 20255 Aug 2025
- Annual report, year to Mar 202414 Aug 2024
- Annual report, year to Mar 202321 Jul 2023, a zip file
- Annual report, year to Mar 202229 Aug 2022, a zip file
Investor presentations2
- Investor Presentation11 Jan 2024
- Investor Presentation15 Nov 2022
Medico Remedies share news and announcements
Newest first. Page 1 of 3.
Sep 2026
29 Sep · Legal
The exchange asked on 29 Sep 2026
22 Sep · Meeting
Aug 2026
29 Aug · General Updates
29 Aug · Meeting
17 Aug · Legal
13 Aug · Results
10 Aug · Board meeting
5 Aug · Business
3 Aug · Legal
Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Jun 2026
29 Jun · Rating
3 Jun · Legal
May 2026
21 May · Results
Apr 2026
16 Apr · Legal
Feb 2026
24 Feb · Legal
18 Feb · Change in Company Secretary/Compliance Officer
12 Feb · Results
12 Feb · Board meeting
Jan 2026
27 Jan · Business
20 Jan · Business
Nov 2025
14 Nov · Results
14 Nov
7 Nov · Business
Oct 2025
6 Oct · Business
Sep 2025
3 Sep
Aug 2025
8 Aug · Results
5 Aug · Corporate action
5 Aug · Meeting
1 Aug · Board meeting
Jul 2025
30 Jul · Board meeting
Jun 2025
22 Jun · Legal
Exchange has sought clarification from Medico Remedies Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
May 2025
15 May · Business
8 May · Results
8 May · Results
Apr 2025
30 Apr · Board meeting
8 Apr · Business
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 14 Aug 2026Resultsdown 4.76%−4.5 pts vs Nifty 500market median −0.7% · five sessions −12.1% (−11.5 pts vs Nifty 500) · volume 1.2× usual · delivery +12.3 pts against usual · The announcement
- 30 Jun 2026Credit ratingdown 4.12%−4.1 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−2.3 pts vs Nifty 500) · volume 2.4× usual · delivery +6.1 pts against usual · The announcement
- 22 May 2026Resultsup 1.53%+1.3 pts vs Nifty 500market median −0.7% · five sessions +1.2% (+0.9 pts vs Nifty 500) · volume 1.9× usual · delivery −30.9 pts against usual · The announcement
- 13 Feb 2026Resultsdown 1.01%+0.4 pts vs Nifty 500market median −0.7% · five sessions −2.9% (−1.4 pts vs Nifty 500) · volume 0.1× usual · delivery +21.6 pts against usual · The announcement
- 17 Nov 2025Resultsdown 0.21%−0.7 pts vs Nifty 500market median −0.7% · five sessions −4.3% (−4.2 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 10 Nov 2025Order receivedup 3.47%+3.2 pts vs Nifty 500market median +1.1% · five sessions +6.6% (+5.3 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 7 Oct 2025Order receivedup 3.46%+3.3 pts vs Nifty 500market median +1.1% · five sessions −0.3% (−0.8 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 11 Aug 2025Resultsdown 0.81%−1.7 pts vs Nifty 500market median −0.7% · five sessions +8.0% (+5.9 pts vs Nifty 500) · volume 0.7× usual · delivery +7.7 pts against usual · The announcement
- 9 May 2025Resultsdown 6.49%−5.7 pts vs Nifty 500market median −0.7% · five sessions −2.0% (−6.4 pts vs Nifty 500) · volume 0.3× usual · delivery +6.0 pts against usual · The announcement
- 9 May 2025Board or managers changeddown 6.49%−5.7 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−6.4 pts vs Nifty 500) · volume 0.3× usual · delivery +6.0 pts against usual · The announcement
7 earlier announcements
- 11 Apr 2025Board or managers changedup 1.93%0.0 pts vs Nifty 500market median 0.0% · five sessions +1.8% (−6.3 pts vs Nifty 500) · volume 0.2× usual · delivery +21.8 pts against usual · The announcement
- 12 Nov 2024Resultsdown 7.70%−6.5 pts vs Nifty 500market median −0.7% · five sessions −25.1% (−22.5 pts vs Nifty 500) · volume 1.8× usual · delivery −9.5 pts against usual · The announcement
- 9 Oct 2024Board or managers changedup 2.00%+1.6 pts vs Nifty 500market median 0.0% · five sessions +2.9% (+2.0 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 13 Aug 2024Resultsdown 2.21%−1.3 pts vs Nifty 500market median −0.7% · five sessions +1.2% (−0.4 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 13 Aug 2024Board or managers changeddown 2.21%−1.3 pts vs Nifty 500market median 0.0% · five sessions +1.2% (−0.4 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 10 May 2024Resultsup 2.77%+2.2 pts vs Nifty 500market median −0.7% · five sessions −2.6% (−5.5 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 16 Aug 2022Resultsdown 4.56%−5.5 pts vs Nifty 500market median −0.7% · five sessions −5.0% (−4.1 pts vs Nifty 500) · volume 3.2× usual · delivery +13.3 pts against usual · The announcement
Medico Remedies results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Earnings per share | Year to date to Dec 2025 | Standalone | 1.74 | 0.87 | −50.0% | 12 Feb 2026 | 13 Apr 2026 |
| Earnings per share | Quarter to Dec 2025 | Standalone | 0.70 | 0.35 | −50.0% | 12 Feb 2026 | 13 Apr 2026 |
| Diluted earnings per share | Year to date to Dec 2025 | Standalone | 1.74 | 0.87 | −50.0% | 12 Feb 2026 | 13 Apr 2026 |
| Diluted earnings per share | Quarter to Dec 2025 | Standalone | 0.70 | 0.35 | −50.0% | 12 Feb 2026 | 13 Apr 2026 |